Selegiline reduces daytime sleepiness in patients with Parkinson's disease

Selegiline reduces daytime sleepiness in patients with Parkinson's disease

Abstract Objectives Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs. Currently, there is no treatment of choice for EDS in PD. Our aim was to check the clinical impression that some patients who wer...

Full description

Bibliographic Details
Main Authors:	Marco Gallazzi, Marco Mauri, Maria Laura Bianchi, Giulio Riboldazzi, Lucia Princiotta Cariddi, Federico Carimati, Valentina Rebecchi, Maurizio Versino
Format:	Article
Language:	English
Published:	Wiley 2021-05-01
Series:	Brain and Behavior
Subjects:	Parkinson’s disease Selegiline sleepiness
Online Access:	https://doi.org/10.1002/brb3.1880

Similar Items

Neuroprotective Effects of Metformin Versus Selegiline on Parkinson’s Disease Model By Reserpine through the Interrelation of α Synuclein and Antioxidants on Behavioral Changes in Rats
by: Ghada Farouk Soliman, et al.
Published: (2019-11-01)

Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management
by: Yun Shen, et al.
Published: (2018-01-01)

Selegiline increases heme oxygenase-1 expression and the cytotoxicity produced by dopamine treatment of neuroblastoma SK-N-SH cells
by: C.R.M. Rieder, et al.
Published: (2004-07-01)

Clinical Features and Correlates of Excessive Daytime Sleepiness in Parkinson's Disease
by: Ya-qin Xiang, et al.
Published: (2019-02-01)

Striatum Shape Hypertrophy in Early Stage Parkinson’s Disease With Excessive Daytime Sleepiness
by: Liang Gong, et al.
Published: (2020-01-01)

Long-term Monitoring Gait Analysis Using a Wearable Device in Daily Lives of Patients with Parkinson’s Disease: The Efficacy of Selegiline Hydrochloride for Gait Disturbance
by: Mutsumi Iijima, et al.
Published: (2017-10-01)

Effect of selegiline on neural stem cells differentiation: a possible role for neurotrophic factors
by: Kambiz Hassanzadeh, et al.
Published: (2015-06-01)

Simple and sensitive high performance liquid chromatographic (HPLC) method for the determination of the selegiline in human plasma
by: Hossein Danafar
Published: (2016-12-01)

Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson’s Disease
by: Motoki Okano, et al.
Published: (2019-08-01)

Evaluation of Daytime Sleepiness in Hypothyroid Patients
by: Selma Pekgör, et al.
Published: (2020-06-01)

White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness
by: Amir Ashraf-Ganjouei, et al.
Published: (2019-04-01)

Experimental pharmacological research regarding the antidepressant effect of associating doxepin and selegiline in normal mice
by: Cornel Chiriță, et al.
Published: (2019-10-01)

Effect of Selegiline on Pituitary- Gonad Axis and Spermatogenesis in Adult Male Rats
by: Mokhtar Mokhtari, et al.
Published: (2005-06-01)

Excessive Daytime Sleepiness Among Depressed Patients
by: Mume CO
Published: (2010-01-01)

Sleepiness and Depression in Parkinson’s Disease Patients Treated with Ropinirole and Levodopa
by: Suk Yun Kang, et al.
Published: (2017-09-01)

Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson’s Disease
by: Hu Y, et al.
Published: (2021-06-01)

Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson’s Disease
by: Satoka Kasai, et al.
Published: (2017-05-01)

Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
by: Hidetomo Murakami, et al.
Published: (2017-09-01)

An investigation into the neuroprotective and neurotoxic properties of levodopa, dopamine and selegiline
by: Scheepers, Mark Wesley
Published: (2008)

Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease
by: M. R. Nodel, et al.
Published: (2018-12-01)

Increased Activation of Default Mode Network in Early Parkinson’s With Excessive Daytime Sleepiness
by: Leon Qi Rong Ooi, et al.
Published: (2019-12-01)

Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer’s Disease: An Animal Model
by: Mudan Cai, et al.
Published: (2020-12-01)

Corrigendum: Increased Activation of Default Mode Network in Early Parkinson's With Excessive Daytime Sleepiness
by: Leon Qi Rong Ooi, et al.
Published: (2020-05-01)

Excessive Daytime Sleepiness
by: Yavuz Selvi, et al.
Published: (2016-06-01)

Clinical and Polysomnographic Characteristics of Patients with Excessive Daytime Sleepiness
by: Yun Kyung Park, et al.
Published: (2018-06-01)

Sex and onset-age-related features of excessive daytime sleepiness and night-time sleep in patients with Parkinson’s disease
by: Ming Liu, et al.
Published: (2021-04-01)

The Top End Sleepiness Scale (TESS): A New Tool to Assess Subjective Daytime Sleepiness Among Indigenous Australian Adults
by: Benn E, et al.
Published: (2021-03-01)

Selegiline acts as neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: Involvement of CREB/BDNF and Akt/GSK3 signal pathways
by: Saba Feizipour, et al.
Published: (2020-05-01)

Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
by: Farbod Fadai, et al.
Published: (2009-12-01)

Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
by: Farbod Fadai, et al.
Published: (2009-12-01)

Selegiline Alleviates the Depressive-Like Behaviors of Methamphetamine Withdrawal Syndrome Through Modulating Mitochondrial Function and Energy Hemostasis
by: Ghavimi, H., et al.
Published: (2022)

Factors influencing excessive daytime sleepiness in adolescents
by: Thiago de Souza Vilela, et al.
Published: (2016-03-01)

Determinants of excessive daytime sleepiness in two First Nation communities
by: Ina van der Spuy, et al.
Published: (2017-12-01)

Altered Amplitude of Low-Frequency Fluctuations and Functional Connectivity in Excessive Daytime Sleepiness in Parkinson Disease
by: Xixi Wang, et al.
Published: (2020-01-01)

Daytime Sleepiness and Sleep Hygiene in Medical Faculty Students
by: Raziye Şule Gümüştakım, et al.
Published: (2020-12-01)

Simplified sleep resistance test for daytime sleepiness detection
by: Luis Darío Larrateguy, et al.
Published: (2021-06-01)

Excessive daytime sleepiness in adolescents: current treatment strategies
by: Matthieu Hein, et al.
Published: (2020-04-01)

In Vitro Expression of BDNF GDNF NGF NT3 and NT4/5 Genes in Selegiline Induced Bone Marrow Stromal Cells
by: Maryam Haji Ghasem Kashani, et al.
Published: (2010-01-01)

The nature of excessive sleepiness and sudden sleep onset in Parkinson׳s disease
by: Daniel Gurgel Fernandes Távora, et al.
Published: (2014-03-01)

Daytime Sleepiness: A Factor Correlated With Mental Health Of Older People
by: Mahshid Foroughan, et al.
Published: (2012-10-01)